Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Eargo, Inc. EAR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
29/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Eargo, Inc. (EAR) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bearish — 2 Hold, 1 Sell.

EAR Analyst Ratings

Hold
3
Ratings
2 Hold
1 Sell
Based on 3 analysts giving stock ratings to Eargo, Inc. in the past 3 months
Rating breakdown
Hold
2 67%
Sell
1 33%
0%
Buy
0 analysts
67%
Hold
2 analysts
33%
Sell
1 analysts

People Also View

AXGN
AXGN
AxoGen, Inc.
$34.76
+0.87%
 HSKA
HSKA
Heska Corporation
$119.99
+0.00%
 SRDX
SRDX
Surmodics, Inc.
$42.98
+0.35%
 NPCE
NPCE
NeuroPace, Inc.
$15.61
+1.69%
 OFIX
OFIX
Orthofix Medical Inc.
$12.87
+1.18%
 KIDS
KIDS
OrthoPediatrics Corp.
$17.85
-0.06%
 ANIK
ANIK
Anika Therapeutics, Inc.
$15.28
-0.13%
 ELMD
ELMD
Electromed, Inc.
$25.71
+1.98%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message